Press release
Incyte Announces Positive CHMP Opinion for Ruxolitinib Cream (Opzelura™) for the Treatment of Non-segmental Vitiligo in Adults and Adolescents
February 24, 2023Business Services
WILMINGTON, Del. – February 24, 2023 – Incyte (Nasdaq:INCY) today announced that the European Medicines Agency (EMA) Committee for Medicinal …
Janssen Receives Positive CHMP Opinion for AKEEGA® (Niraparib and Abiraterone Acetate Dual Action Tablet) Plus Prednisone or Prednisolone for the Treatment of Adult Patients with BRCA1/2 Gene-Mutated Metastatic Castration Resistant Prostate Cancer
February 24, 2023Business Services
BEERSE, Belgium, 24 February 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that the Committee for …
Automata launches the LINQ platform to fully automate workflows and the transport of labware in every lab space
February 24, 2023Business Services
24th February 2023 – Automata, a leading automation company powering life science labs to fully automate their workflows, today launches
AviadoBio Signs Exclusive License Agreement with Neurgain Technologies for Novel Gene Therapy Spinal Delivery Technology
February 24, 2023Business Services
LONDON–(BUSINESS WIRE)–AviadoBio, a pioneering gene therapy company developing and delivering transformative medicines for neurodegenerative disorders and Neurgain Technologies, Inc., an …
UiPath Helps Mitsubishi Tanabe Pharma Accelerate Business Operational Efficiency
February 23, 2023Business Services
February 23, 2023 – UiPath (NYSE: PATH), a leading enterprise automation software company, today announced that Mitsubishi Tanabe Pharma Corporation, …
NICE recommends first immunotherapychemotherapy combination for neoadjuvant treatment of resectable non-small-cell lung cancer
February 23, 2023Business Services
(Uxbridge, Middlesex, 22 February 2023) – Bristol Myers Squibb (BMS) has announced that the National Institute for Health and Care …
LEADING BUILD TO RENT OPERATOR LAUNCHES SECTOR-FIRST PRESCRIPTION SERVICE WITH NATIONAL PHARMACY CHAIN
February 23, 2023Business Services
Moda Living, the UK’s leading developer and operator of rental communities, has today announced a partnership with VideoGP by LloydsPharmacy, …
Pandemic Antiviral Discovery (PAD) makes first investments to support the development of new antiviral medicines for future pandemics
February 23, 2023Business Services
Today, the partners in Pandemic Antiviral Discovery (PAD) initiative announced grants totalling more than USD 26 million for 14 research …
8 out of 10 pharmaceutical companies say developing Covid tests and vaccines has impacted their development pipeline
February 23, 2023Business Services
LONDON 23rd February 2023
OSE Immunotherapeutics Updates on Anti-IL-7 Receptor Antagonist OSE-127/S95011, a Breakthrough Approach in Chronic Inflammatory Autoimmune Diseases and Hematology
February 22, 2023Business Services
Nantes, France – February 22, 2023, 6:00 p.m.
PHARMANOVIA ENTERS IN-LICENSING AGREEMENT WITH AXSOME THERAPEUTICS TO MARKET AND FURTHER DEVELOP SUNOSI® (SOLRIAMFETOL), A FIRST-IN-CLASS TREATMENT FOR EXCESSIVE DAYTIME SLEEPINESS (EDS) IN PEOPLE WITH NARCOLEPSY AND OBSTRUCTIVE SLEEP APNOEA
February 22, 2023Business Services
BASILDON, UK, 22 February 2023 Pharmanovia, a global pharmaceutical company that revitalises, extends and expands the lifecycle of already …
Relation Therapeutics announces launch of flagship integrated wet–dry laboratory at the heart of London’s Knowledge Quarter
February 22, 2023Business Services
London, February 22, 2023 – Relation Therapeutics, a leader in the use of high-resolution biology, machine learning and clinical insights …
NICE Publishes Reimbursement Recommendation for Translarna™
February 22, 2023Business Services
London, UK, 22nd February, 2023 — PTC Therapeutics, Ltd. today announced the National Institute for Health and Care Excellence (NICE) has published …
Indegene launches Metaverse capabilities to help life sciences companies create immersive healthcare experiences
February 22, 2023Business Services
Princeton, United States / Bengaluru, India, February 21, 2023: Indegene, a digital-first, life sciences commercialization company today announced the launch …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
